NCT03671122View on ClinicalTrials.gov

PREFERS (Preserved and Reduced Ejection Fraction Epidemiological Regional Study) Stockholm Heart Failure Study

CompletedOBSERVATIONAL
Enrollment

683

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

January 31, 2021

Study Completion Date

February 28, 2021

Conditions
Heart Failure, DiastolicHeart Failure，Congestive
Interventions
DIAGNOSTIC_TEST

Cardiac imaging in the PREFERS and CABG PREFERS cohorts

performed at baseline and after 1 year

OTHER

Biomarker analysis in the PREFERS and CABG PREFERS chorts

blood samples will be taken for biomarker analysis at baseline and after 1 year

PROCEDURE

Cardiac biopsies in the CABG PREFERS cohort

myocardial biopsies from the right trium the left and right ventricles will be taken during elective CABG

Trial Locations (1)

17176

Karolinska Institutet, Stockholm

All Listed Sponsors
collaborator

The Swedish Research Council

OTHER_GOV

collaborator

Region Stockholm

OTHER_GOV

lead

Karolinska Institutet

OTHER

NCT03671122 - PREFERS (Preserved and Reduced Ejection Fraction Epidemiological Regional Study) Stockholm Heart Failure Study | Biotech Hunter | Biotech Hunter